Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Sex: All
Age: 0 - 21
Code: NCT05849662
Phase 1, Phase 2, Recruiting
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
for
Multiple Sclerosis
Location: West Hollywood CA, Lancaster CA, Phoenix AZ,
Sponsor: Sanofi
Sex: All
Age: 18 - 60
Code: NCT07325292
Phase 3, Recruiting
Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
for
Localized Prostate Adenocarcinoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: Male
Age: 18+
Code: NCT07276438
Recruiting
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
for
B-All, Acute Lymphoblastic Leukemia
Location: Los Angeles CA, Salt Lake City UT, Seattle WA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 25
Code: NCT05621291
Recruiting
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
for
Functional Hypothalamic Amenorrhea, FHA
Location: West Hills CA, Phoenix AZ, Portland OR, Erie PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18 - 40
Code: NCT07235917
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene
for
Burkitt Lymphoma, Double-Expressor Lymphoma,
Location: Orange CA, Irvine CA, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07069699
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Los Angeles CA, Orange CA, Phoenix AZ, Eugene OR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
International Rare Histiocytic Disorders Registry (IRHDR)
for
Rare Histiocytic Disorders (RHDs),
Location: Los Angeles CA, Madera CA, Birmingham AL, Pittsburgh PA,
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0+
Code: NCT02285582
Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Fullerton CA, Orange CA, Phoenix AZ, Scottsdale AZ,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue